Trauma-induced coagulopathy: An institution's 35 year perspective on practice and research

Scandinavian Journal of Surgery

Volumn 103, Issue 2, 2014, Pages 89-103

  Gonzalez, E ^a,b   Moore, Ernest E ^a,b   Moore, H B ^a,b   Chapman, M P ^a   Silliman, C C ^a,c,d   Banerjee, A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

^d Bonfils Blood Center   (United States)

Author keywords

Coagulopathy; Fibrinolysis; Hemorrhage; ROTEM; Thrombelastography; Transfusion; Trauma

Indexed keywords

EID: 84902659148     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1457496914531927     Document Type: Review

References (87)

1. The State of US Health, 1990-2010: Burden of diseases, injuries, and risk factors. JAMA 2013;310:591-608.
2. Sauaia A, Moore FA, Moore EE et al: Epidemiology of trauma deaths: A reassessment. J Trauma 1995;38:185-193.
3. Stefanini M: Basic mechanisms of hemostasis. Bull N Y Acad Med 1954;30:239-277.
4. Scott R Jr, Crosby WH: Changes in the coagulation mechanism following wounding and resuscitation with stored blood; A study of battle casualties in Korea. Blood 1954;9:609-621.
5. Simmons RL, Collins JA, Heisterkamp CA: Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg 1969;169:455-482.
6. Kashuk JL, Moore EE, Millikan JS et al: Major abdominal vascular trauma-A unified approach. J Trauma 1982;22:672-679.
7. Dunn EL, Moore EE, Breslich DJ et al: Acidosis-induced coagulopathy. Surg Forum 1979;30:471-473.
8. Stone HH, Strom PR, Mullins RJ: Management of the major coagulopathy with onset during laparotomy. Ann Surg 1983;197:532-535.
9. Ruttmann TG, James MF, Aronson I: In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998;80:612-616.
10. Maegele M, Lefering R, Yucel N et al: Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury 2007;38:298-304.
11. Wohlauer MV, Moore EE, Gonzalez E et al: Hemodilution is not critical in the pathogenesis of the acute coagulopathy of trauma. J Surg Res 2012;173:26-30.
12. Hoffman M, Monroe DM: A cell-based model of hemostasis. Thromb Haemost 2001;85:958-965.
13. Furie B, Furie BC: Mechanisms of thrombus formation. N Engl J Med 2008;359:938-949.
14. Goto S, Ikeda Y, Ruggeri ZM et al: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998;101:479-486.
15. Ruggeri ZM: Old concepts and new developments in the study of platelet aggregation. J Clin Invest 2000;105:699-701.
16. Whelihan MF, Mann KG: The role of the red cell membrane in thrombin generation. Thromb Res 2013;131:377-382.
17. Brohi K, Cohen MJ, Pittet JF et al: Acute traumatic coagulopathy: Initiated by hypoperfusion: Modulated through the protein C pathway? Ann Surg 2007;245:812-818.
18. Cohen MJ, Esmon CT, Brohi K et al: Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012;255:379-385.
19. Esmon CT: The endothelial protein C receptor. Curr Opin Hematol 2006;13:382-385.
20. L evi M, Toh CH, Watson HG et al: Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009;145:24-33.
21. Taylor FB Jr, Toh CH, Levi M et al: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-1330.
22. L evi M, ten Cate H, van der Poll T et al: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993;270:975-979.
23. Gando S: Acute coagulopathy of trauma shock and coagulopathy of trauma: A rebuttal. You are now going down the wrong path. J Trauma 2009;67:381-383.
24. Schochl H, Frietsch T, Pavelka M et al: Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009;67:125-131.
25. Chesebro BB, Rahn P, Brohi K et al: Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock 2009;32:659-665.
26. Kashuk JL, Moore EE, Wohlauer M et al: Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010;252:434-442.
27. Kapsch DN, Metzler M, Harrington M et al: Fibrinolytic response to trauma. Surgery 1984;95:473-478.
28. Cotton BA, Harvin JA, Schochl H et al: Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012;73:365-370.
29. Chapman MP, Moore EE, Harr JN et al: Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013;75:961-967.
30. Raza I, Davenport R, Rourke C et al: The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013;11:307-314.
31. Dejouvencel T, Doeuvre L, Lacroix R et al: Fibrinolytic cross-talk: A new mechanism for plasmin formation. Blood 2010;115:2048-2056.
32. Plow EF, Doeuvre L, Das R: So many plasminogen receptors: Why? J Biomed Biotechnol 2012;2012:141806.
33. Byeon IJ, Llinas M: Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J Mol Biol 1991;222:1035-1051.
34. Carpenter SL, Mathew P: Alpha2-antiplasmin and its deficiency: Fibrinolysis out of balance. Haemophilia 2008;14:1250-1254.
35. Foley JH, Kim PY, Mutch NJ et al: Insights into thrombin activatable fibrinolysis inhibitor function and regulation. J Thromb Haemost 2013;11(Suppl. 1):306-315.
36. Abiko Y, Iwamoto M, Tomikawa M: Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor. Biochim Biophys Acta 1969;185:424-431.
37. Van Mourik JA, Lawrence DA, Loskutoff DJ: Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem 1984;259:14914-14921.
38. Rezaie AR: Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001;276:15567-15570.
39. Kutcher ME, Redick BJ, McCreery RC et al: Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012;73:13-19.
40. Sillesen M, Johansson PI, Rasmussen LS et al: Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg 2013;74:1252-1259.
41. Wohlauer MV, Moore EE, Sauaia A et al: Early platelet dysfunction: An unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012;214:739-746.
42. Johansson PI, Sorensen AM, Perner A et al: High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost 2012;10:207-216.
43. Johansson PI, Stensballe J, Ostrowski SR et al: A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011;254:194-200.
44. Cohen MJ, Kutcher M, Redick B et al: Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg 2013;75:S40-S47.
45. Owen CA Jr: Historical account of tests of hemostasis. Am J Clin Pathol 1990;93:S3-S8.
46. Eckman MH, Erban JK, Singh SK et al: Screening for the risk for bleeding or thrombosis. Ann Intern Med 2003;138:W15-W24.
47. Brohi K, Cohen MJ, Davenport RA: Acute coagulopathy of trauma: Mechanism, identification and effect. Curr Opin Crit Care 2007;13:680-685.
48. Kashuk JL, Moore EE, Johnson JL et al: Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma 2008;65:261-270.
49. Hoyt DB, Dutton RP, Hauser CJ et al: Management of coagulopathy in the patients with multiple injuries: Results from an international survey of clinical practice. J Trauma 2008;65:755-764.
50. MacLeod JB, Lynn M, McKenney MG et al: Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55:39-44.
51. Hess JR, Lindell AL, Scalea TM et al: The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009;49:34-39.
52. Maegele M: Coagulopathy after traumatic brain injury: Incidence, pathogenesis, and treatment options. Transfusion 2013;53:28s-37s.
53. Jacoby RC, Owings JT, Holmes J et al: Platelet activation and function after trauma. J Trauma 2001;51:639-647.
54. Nunez TC, Voskresensky IV, Dossett LA et al: Early prediction of massive transfusion in trauma: Simple as ABC (assessment of blood consumption)? J Trauma 2009;66:346-352.
55. De Nicola P, Mazzetti GM: Evaluation of thrombelastography. Am J Clin Pathol 1955;23:447-452.
56. Kang YG, Martin DJ, Marquez J et al: Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-896.
57. Gonzalez E, Pieracci FM, Moore EE et al: Coagulation abnormalities in the trauma patient: The role of point-of-care thromboelastography. Semin Thromb Hemost 2010;36:723-737.
58. Gonzalez E, Kashuk JL, Moore EE et al: Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta). J Surg Res 2010;163:96-101.
59. Schochl H, Voelckel W, Grassetto A et al: Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg 2013;74:1587-1598.
60. Rivard GE, Brummel-Ziedins KE, Mann KG et al: Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005;3:2039-2043.
61. White NJ, Martin EJ, Brophy DF et al: Coagulopathy and traumatic shock: Characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation 2010;81:111-116.
62. Harr JN, Moore EE, Sauaia A et al: Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013;39:45-49.
63. Aleshnick M, Orfeo T, Mann K et al: Interchangeability of rotational elastographic instruments and reagents. J Trauma Acute Care Surg 2014;76:107-113.
64. Hagemo JS, Naess PA, Johansson P et al: Evaluation of TEG® and RoTEM® inter-changeability in trauma patients. Injury 2013;44:600-605.
65. Kutcher ME, Kornblith LZ, Narayan R et al: A paradigm shift in trauma resuscitation: Evaluation of evolving massive transfusion practices. JAMA Surg 2013;148:834-840.
66. Tapia NM, Chang A, Norman M et al: TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg 2013;74:378-385.
67. Cotton BA, Gunter OL, Isbell J et al: Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008;64:1177-1182.
68. Silliman CC, Moore EE, Le T et al: One to one to what? Transfusion 2010;50:2066-2067.
69. Holcomb JB, Wade CE, Michalek JE et al: Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248:447-458.
70. Snyder CW, Weinberg JA, McGwin G Jr et al: The relationship of blood product ratio to mortality: Survival benefit or survival bias? J Trauma 2009;66:358-362.
71. Schochl H, Nienaber U, Hofer G et al: Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55.
72. Kashuk JL, Moore EE, Sawyer M et al: Postinjury coagulopathy management: Goal directed resuscitation via POC thrombelastography. Ann Surg 2010;251:604-614.
73. Spinella PC, Perkins JG, Grathwohl KW: Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009;66: S69-S76.
74. Cotton BA, Podbielski J, Camp E et al: A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg 2013;258:527-532.
75. Schlimp CJ, Voelckel W, Inaba K et al: Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrinbased clot strength (FIBTEM) in major trauma: A retrospective study. Scand J Trauma Resusc Emerg Med 2013;21:74.
76. Dickneite G, Dorr B, Kaspereit F et al: Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010;68:1151-1157.
77. Moore EE, Chin TL, Chapman MC et al: Plasma first in the field for postinjury hemorrhagic shock. Shock. Epub ahead of print 5 December 2013. DOI: 10.1097/SHK.0000000000000110.
78. Silliman CC, Dzieciatkowska M, Moore EE et al: Proteomic analyses of human plasma: Venus versus Mars. Transfusion 2012;52:417-424.
79. Schmidt EP, Yang Y, Janssen WJ et al: The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 2012;18:1217-1223.
80. Peng Z, Pati S, Potter D et al: Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 2013;40:195-202.
81. Limentani SA, Roth DA, Furie BC et al: Recombinant blood clotting proteins for hemophilia therapy. Semin Thromb Hemost 1993;19:62-72.
82. Shakur H, Roberts I, Bautista R et al: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010;376:23-32.
83. Morrison JJ, Dubose JJ, Rasmussen TE: Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012;147:113-119.
84. Napolitano LM, Cohen MJ, Cotton BA et al: Tranexamic acid in trauma: How should we use it? J Trauma Acute Care Surg 2013;74:1575-1586.
85. Mannucci PM, Ruggeri ZM, Pareti FI et al: 1-Deamino-8-d-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet 1977;1:869-872.
86. Mannucci PM, Levi M: Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-2311.
87. Hanke AA, Dellweg C, Kienbaum P et al: Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: An in vitro study using multiple electrode aggregometry. Anaesthesia 2010;65:688-691.